echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuan

    Jiangxi's domestic bivalent cervical cancer vaccine "starts up" costs only 1,000 yuan

    • Last Update: 2021-06-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    On April 19, according to Jiangxi's announcement, the domestically-made cervical cancer bivalent vaccine will land in Jiangxi.
    It costs about 1,000 yuan to complete the entire vaccination process, which is half the price of the imported bivalent vaccine.
    It is suitable for those 9 to 45 years old and 9 to 14 years old.
    Only two vaccination can prevent the two most dangerous precancerous lesions, so that the age-appropriate population can effectively avoid the risk of cervical cancer.

    At present, the cervical cancer vaccines marketed in Jiangxi Province include imported bivalent, quadrivalent, and quaternary vaccines and domestic bivalent vaccines.

    Source: Published by Jiangxi

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.